相关实验视频

Updated: Jun 22, 2025

Enhancing Tumor Content through Tumor Macrodissection

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

在扩散性大B细胞淋巴瘤中,新的点和先进疗法

Francesco D'Alò^1,2, Silvia Bellesi³, Elena Maiolo³

¹Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.

|June 27, 2024

概括

包括单克隆抗体和细胞疗法在内的向疗法正在彻底改变B细胞淋巴瘤治疗. 这些创新为扩散型大B细胞淋巴瘤 (DLBCL) 提供了超越传统化疗的改善结果和个性化策略.

科学领域:

血液学和瘤学研究
免疫学免疫学免疫学
分子生物学分子生物学

背景情况:

自从Rituximab推出以来,针对B细胞淋巴瘤的向疗法已经取得了重大进展,改善了患者的预后.
了解疾病生物学和诊断对于开发新的治疗策略至关重要.
传统化疗因化学折射性和毒性而面临局限性,需要个性化治疗方法.

研究的目的:

审查新兴的淋巴瘤细胞点.
探索扩散型大B细胞淋巴瘤 (DLBCL) 的创新疗法.
为DLBCL治疗新型疗法的未来影响提供见解.

主要方法:

关于针对B细胞淋巴瘤的向疗法的当前文献的综述.
分析新兴的治疗方式,包括化学抗原受体-T细胞,单克隆抗体,抗体-药物联合体,双特异性抗体,检查点抑制剂和小分子.
检查免疫类型和分子诊断方面的进展.

主要成果:

向药物与化疗的整合改善了反应率和生存率.
创新疗法开始取代传统的细胞毒药物,并挑战传统的救援策略.
广泛的新型治疗药物显示出促进DLBCL治疗的前景.

结论:

面向创新的向疗法的范式转变正在改变DLBCL治疗.
新兴疗法为改善患者治疗结果和个性化医疗提供了有希望的途径.
对于DLBCL管理的未来,对新目标和治疗方式的持续研究至关重要.

关键词:

在BCL2抑制剂的使用中.的BTK抑制剂.作为XPO1抑制剂的使用.抗体药物联合体抗体药物联合体两种特异性的抗体.检查点抑制剂检查点抑制剂仿真抗原受体-T细胞的T细胞扩散大的B细胞淋巴瘤.

更多相关视频

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...